Important Notice for ModivCare Inc. Shareholders
New York, NY, March 20, 2025
The Gross Law Firm, a leading national securities fraud law firm, issues this notice to all ModivCare Inc. (MODV) shareholders. The firm is investigating potential securities fraud claims on behalf of shareholders who purchased ModivCare securities during the period from February 1, 2023, to August 31, 2024, inclusive (the “Class Period”).
Allegations of Securities Fraud
The investigation focuses on allegations that ModivCare and certain of its executives or directors may have violated securities laws and/or engaged in other unlawful business practices. Specifically, the investigation concerns whether the Company and its executives or directors made false and/or misleading statements and/or failed to disclose: (1) the Company’s financial condition; (2) the Company’s business practices; and (3) the Company’s compliance with applicable laws and regulations.
Lead Plaintiff Eligibility
If you purchased shares of ModivCare during the Class Period and suffered a loss, you may be eligible to serve as a lead plaintiff in this action. The lead plaintiff is usually the class member who has the largest financial investment and is most adversely affected by the alleged fraud. The lead plaintiff plays a significant role in the litigation and will be responsible for working with the law firm to represent the interests of the class.
Contact The Gross Law Firm
If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact The Gross Law Firm as soon as possible at 888-228-9133, or by emailing the firm at [email protected]. You may also contact the firm by filling out the form on its website, [email protected], or by visiting www.grosslawfirm.com/contact-us.
Impact on Individual Shareholders
The investigation and potential lawsuit against ModivCare may negatively impact the Company’s stock price. If the allegations are proven true, the Company may face significant financial penalties and damages, which could further decrease the stock price. Shareholders who purchased ModivCare securities during the Class Period may be able to recover their losses through this lawsuit.
Impact on the World
The securities fraud investigation and potential lawsuit against ModivCare could have wider implications for the investment community. If the allegations are proven true, it could serve as a reminder of the importance of transparency and honesty in corporate reporting and governance. It could also encourage other shareholders to come forward and pursue similar actions against other companies that may be engaging in similar practices. Moreover, it could lead to increased scrutiny of the healthcare industry, which has seen a surge in mergers and acquisitions in recent years.
Conclusion
The Gross Law Firm is committed to protecting the rights of shareholders and pursuing justice on their behalf. If you purchased ModivCare securities during the Class Period and believe you may have been affected by the alleged fraud, we encourage you to contact our firm to discuss your options. Together, we can hold those responsible accountable and seek to recover your losses.
- The Gross Law Firm is investigating potential securities fraud claims against ModivCare.
- The investigation concerns allegations that the Company and certain executives or directors made false and/or misleading statements and failed to disclose important information.
- Shareholders who purchased ModivCare securities during the Class Period may be eligible to serve as a lead plaintiff in this action.
- Individual shareholders may be able to recover their losses through this lawsuit.
- The investigation and potential lawsuit could have wider implications for the investment community and the healthcare industry.
